Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on Nov 08, 2016 4:17pm
116 Views
Post# 25438427

RE:RE:Angoracom

RE:RE:AngoracomWell BDAZ, as much as I value and respect your perspectives this is one time when I do feel you have over stepped your authority and judgement.

I've tried to avoid posting in regards to what I consider the trivial nonsense that has been going on at Agoracom but now I must comment.

Frankly I think Hartland’s questions (???) are good speculation. Why? Because his POVs spark thoughts and perspectives for me. He may be coming at this from many angles and I have no idea of what they may be and I don’t care. He may be a poop disturber (I assume the other word can't be used). But he or she does raise questions that provoke new thoughts for me. 

Other than the nastiness of Prince of Cut (who also raised very significant business issues to his/her credit) generally speaking the discourse on Stockhouse, Agoracom and Investor Village has retained the high ground in terms of civility of thoughtful discourse until this recent period of information vacuum. That will be settled soon and we will move to the next round of development.
 
However, in this stage of anxiety (my judgement) the conversation has devolved and there is little value in that. Let’s raise the bar!
 
One of the posters we have lost is Tundup. I considered his/her business perspective to have been brilliant and he/she may be lurking in the background (pure fun speculation on this… hahaha!).
 
So Hartland, narmac and others keep the thinking coming! I’m not a trader. I’m long. I believe in the science and I do not care about the short-term games.
 
Let us be very careful of censorship. Critical thinking is what is required…research, depth, experience, people with close proximity with this company and their perspectives, analysts with depth in biotech and BP.
 
BDAZ, keep giving us the fantastic understanding of the science! It seems that you are the one poster who can actually communicate the Resverlogix/Zenith accomplishments in terms I can understand! Keep it up Buddy!
 
Cheers
Toinv
Bullboard Posts